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Abstract
Background: The Nkx3.2 transcription factor promotes chondrogenesis by forming a positive regulatory loop with a crucial
chondrogenic transcription factor, Sox9. Previous studies have indicated that factors other than Sox9 may promote
chondrogenesis directly, but these factors have not been identified. Here, we test the hypothesis that Nkx3.2 promotes
chondrogenesis directly by Sox9-independent mechanisms and indirectly by previously characterized Sox9-dependent
mechanisms.
Methodology/Principal Findings: C3H10T1/2 pluripotent mesenchymal cells were cultured with bone morphogenetic
protein 2 (BMP2) to induce endochondral ossification. Overexpression of wild-type Nkx3.2 (WT-Nkx3.2) upregulated
glycosaminoglycan (GAG) production and expression of type II collagen a1( Col2a1) mRNA, and these effects were evident
before WT-Nkx3.2-mediated upregulation of Sox9. RNAi-mediated inhibition of Nkx3.2 abolished GAG production and
expression of Col2a1 mRNA. Dual luciferase reporter assays revealed that WT-Nkx3.2 upregulated Col2a1 enhancer activity in
a dose-dependent manner in C3H10T1/2 cells and also in N1511 chondrocytes. In addition, WT-Nkx3.2 partially restored
downregulation of GAG production, Col2 protein expression, and Col2a1 mRNA expression induced by Sox9 RNAi. ChIP
assays revealed that Nkx3.2 bound to the Col2a1 enhancer element.
Conclusions/Significance: Nkx3.2 promoted primary chondrogenesis by two mechanisms: Direct and Sox9-independent
upregulation of Col2a1 transcription and upregulation of Sox9 mRNA expression under positive feedback system.
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Introduction
During endochondral ossification, chondrogenesis is executed in
multiple steps [1]. In the early steps of chondrogenesis, the Sox9
transcription factor is a crucial inducer of the expression of
chondrocyte-specific genes [2,3]. However, the latter steps of
chondrogenesis are regulated by Runx-family transcription factors
[4,5]. We recently reported that hypoxia (5% oxygen tension)
promotes chondrogenesis and glycosaminoglycan (GAG) produc-
tion and that it suppresses hypertrophy of chondrocytes and
osteoblastic differentiation in C3H10T1/2 cell culture [6]. Nkx3.2
(also known as Bapx1), a member of the NK homeobox gene
family, is a transcriptional repressor that regulates Runt related
transcription factor 2 (Runx2) expression as part of a tight positive
regulatory system that includes Sox9; this system is initiated by
Sonic hedgehog (Shh) [7,8,9,10]. Lassar’s group demonstrated that
Nkx3.2 also promotes primary chondrogenic differentiation using
primary presomitic mesodermal explants [7], but a direct, Sox9-
independent relationship between Nkx3.2 and type II collagen a1
(Col2a1), a marker of primary chondrogenic differentiation, has
not been reported.
In humans, a rare form of skeletal dysplasia, called spondylo-
megaepiphysial-metaphysial dysplasia (SMMD), is caused by
homozygous inactivating mutations in the NKX3.2 gene [11].
The skeletal phenotypes seen in SMMD patients are mor-
phologically similar to those observed in Nkx3.2 null mice [12].
The human and mouse Nkx3.2 mutations are associated not only
with severe dysplasia of vertebral column, but also arrested
development of intervertebral discs, which is similar to that
seen in Col2a1 null mice [13]. Therefore, we hypothesized that
there must be a Sox9-independent mechanism for Nkx3.2
to promote primary chondorogenesis by activating Col2a1
transcription.
Here, we used the C3H10T1/2 pluripotent mesenchymal
cell line and the N1511 murine chondrocyte cell line and
demonstrated that Nkx3.2 promotes primary chondrogenesis
during endochondral ossification by directly activating Col2a1
transcription.
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Cell Culture and Analysis for Chondrogenic
Differentiation
C3HT101/2 cells were purchased from RIKEN Bio-Resource
Center (Saitama, Japan) and were cultured in Dulbecco’s modified
Eagle’s medium (Invitrogen, San Diego, CA). The N1511 murine
chondrocyte cell line [14], which was kindly donated by Dr.
Hideto Watanabe and Dr. Nobuhiro Kamiya, was also cultured in
Dulbecco’s modified Eagle’s medium. When cultures were
approximately 90% confluent, recombinant human bone mor-
phogenic protein 2 (rh-BMP2), which was donated by Osteo-
pharma Inc. (Osaka, Japan), was added to stimulate chondrogen-
esis. To evaluate chondrogenic differentiation, C3H10T1/2 cells
were fixed with 10% formalin and then washed with 0.1N HCl in
distilled water; washed cells were stained for 60 min with alcian
blue solution, alcian blue 8GX (Sigma, St. Louis, MO) and rinsed
twice with 0.1 N HCl to remove any unbound dye. To quantify
GAG synthesis, alcian blue is extracted by 4 M guanidine-HCl
overnight at 4uC. Absorbance values are read at 600 nm after
temperature equilibration.
Proliferation assay
C3H10T1/2 cells were cultured in 96-well plates at a
concentration of 1.0610
4 cells/cm
2, and they were stimulated
with rh-BMP2 (300 ng/ml). Cell proliferation was assessed using
the Cell Counting Kit-8 assay system (Dojindo, Kumamoto,
Japan), according to the manufacturer’s instructions.
Western blot analysis
Western blot analyses were performed using whole cell lysates.
For the blots, 20 mg of each sample was applied. The blots were
first incubated with anti-mouse collagen II antibodies (R&D
Systems Inc., Minneapolis, MN) and then with horseradish
peroxidase-conjugated anti- sheep IgG antibodies (R&D Systems
Inc., Minneapolis, MN). Anti-mouse b-actin rabbit antibodies and
horseradish peroxidase-conjugated anti-rabbit IgG antibodies
were purchased from Cell Signaling Technology (Tokyo, Japan).
RNA interference and overexpression of Nkx3.2 and Sox9
Commercially synthesized small interfering RNA (siRNA) and
manufacturer’s protocols were used for the RNAi experiments (B-
Bridge International, Inc., Cupertino, CA). The sequences of sense
strands of siRNA targeting Nkx3.2 and Sox9 mRNA and that of the
negative control siRNA are shown in Table 1. The wild-type Sox9
(WT-Sox9) construct was donated by the Department of
Biochemistry, Osaka University Graduate School, Faculty of
Dentistry. The wild-type Nkx3.2 (WT-Nkx3.2) plasmid was
constructed by inserting a full-length Nkx3.2 cDNA into the
pBApo-CMV Neo vector purchased from Takara Bio Inc., Otsu,
Japan. When cultures were approximately 70% confluent, 10 nM
of Nkx3.2 or Sox9 siRNA were transfected with 10 mM
Lipofectamine RNAiMAX (Invitrogen). After 24-h transfection,
MOCK plasmid or WT-Nkx3.2/Sox9 was transiently transfected
by using FuGENEH6 transfection reagent (Roche, Indianapolis,
IN) according to the manufacture’s recommendation. After
another 24-h culture (day 0), cells were continuously stimulated
with BMP-2 (300 ng/ml) and cultured with the medium change at
3 days intervals.
Reporter Constructs and Luciferase Reporter Assay
Four tandem copies of a 48-bp chondrocyte-specific enhancer
segment from the type II collagen a1 (Col2a1) gene were synthesized
as previously reported [15] and inserted into the pGL3-Promoter
vector (Promega, Madison, WI); this construct was designated
4Col2E-Luc. A GTGAAT motif was deleted from this 48-bp
enhancer segment to generate a 42-bp segment; an array of four
tandem copies of this 42-bp segment was synthesized and inserted
into the pGL3-Promoter vector purchased from UNITECH
(Chiba, Japan). This construct was designated D4Col2E-Luc. In
reporter assays, cells were transiently transfected with 0.4 mg of the
4Col2E-Luc or the D4Col2E-Luc construct and 0.01 mg of the
TK-Renilla luciferase construct (TK Renilla) (Promega). Luciferase
activity was measured using a Dual Luciferase assay kit (Promega)
and luminometer (Berthold Technologies, Bad Wildbad, Ger-
many), and reporter construct activity was normalized by
comparison with activity from the Renilla luciferase construct. All
experiments were performed in triplicate.
Chromatin immunoprecipitation (ChIP)
Chromatin immunoprecipitation (ChIP) was performed using
an EZ ChIP kit (Millipore, Billerica, MA). Anti-Nkx3.2 mouse
antibodies, anti-Sox9 mouse antibodies, and normal rabbit
immunoglobulin G (IgG) were all purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). Qualitative PCR conditions
were as follows: 1 cycle at 95uC for 2 min; 35 cycles at 95uC for
30 s, 60uC for 30 min, and 72uC for 30 min; and 1 cycle at 72uC
for 7 min. Products were electrophoresed on a 3% agarose gel.
ChIP primers targeting the Col2a1 enhancer are shown in Table 2.
Standard and Quantitative RT-PCR
First-strand cDNA was synthesized using SuperScript III RNase
HH reverse transcriptase (Invitrogen). Standard RT-PCR was
performed using Ex Taq (Takara Bio Inc.). Quantitative RT-PCR
was performed using the Roche Applied Science Light Cycler
system. The SYBR Green assay, with which each cDNA sample
was evaluated in triplicate 20-ml reactions, was used for all target
transcripts. Expression values were normalized to GAPDH
expression. The sequence of the primers used for standard and
quantitative RT-PCR assays, are shown in Table 3.
Statistical analysis
All data are expressed as the mean 6 standard deviation (SD) of
a minimum of three replicate measurements. Differences between
Table 1. Sequences of sense strands of siRNA targeting
Nkx3.2, Sox9 mRNA and of siRNA control.
Target gene Oligonucleotide Sequence (59R39 )
Negative control Sense ATCCGCGCGATAGTACGTA
Nkx3.2 Sense CCAAGGACCUGGAGGAGGATT
Sox9 Sense GCCAGGUGCUGAAGGGCUATT
doi:10.1371/journal.pone.0034703.t001
Table 2. Primer sequences used in ChIP analysis of the Col2a1
enhancer.
Primer Sequence (59R39 )
Forward GGGAGACCTCAGTCCTCCTT
Reverse AGAAAGGAGCCAACGCTGTA
doi:10.1371/journal.pone.0034703.t002
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was considered statistically significant.
Results
Overexpression of Nkx3.2 promotes and inhibition of
Nkx3.2 suppresses chondrogenic differentiation and GAG
production in C3H10T1/2 cell culture
On days 5, 7, and 10, GAG production was higher in
C3H10T1/2 cells overexpressing Nkx3.2 than in control cells
(Fig. 1a, b). Expression of Col2a1 mRNA was upregulated on days
5 and 7, and Runx2 mRNA was downregulated on days 5, 7, and
10 in cells overexpressing Nkx3.2. However, Sox9 expression was
not upregulated until day 7 (Fig. 2a, b). Overexpression of Nkx3.2
upregulated cell proliferation in C3H10T1/2 cells on day 2, but
no differences in cell proliferation were observed between control
cells and overexpressing cells after day 5 (Fig. 1c). Inhibition of
Nkx3.2 using RNAi clearly suppressed GAG production on days 5,
7 and 10 (Fig. 1d, e) and expression of Col2a1, and Sox9 mRNA,
while upregulated Runx2 expression on days 2, 5, and 7 (Fig. 2c, d).
Inhibition of Nkx3.2 downregulated the proliferation of
C3H10T1/2 cells on day 2, but no differences in cell proliferation
were observed after day 5 (Fig. 1f).
Nkx3.2 binds to the 48-bp chondrocyte-specific enhancer
segments of Col2a1 and upregulates Col2a1 transcription
To assess the effects of Nkx3.2 on Col2a1 enhancer activity, we
performed a dual luciferase activity assay. The D4Col2E-Luc
construct carried a deleted version of the enhancer carried in the
4Col2E-Luc construct; specifically, the enhance repeats in
D4Col2E-Luc lack a GTGAAT motif (Fig. 3). WT-Nkx3.2
upregulated Col2a1 enhancer activity in a dose-dependent manner
(Fig. 4a). Next, we compared the activity from the 4Col2E-Luc
and D4Col2E-Luc constructs in the presence of WT-Nkx3.2 or
WT-Sox9 (Fig. 4b, c). Both WT-Nkx3.2 and WT-Sox9 clearly
upregulated the transcriptional activity of 4Col2E-Luc (Fig. 4b).
Moreover, WT-Nkx3.2 upregulated transcriptional activity of
4Col2E-Luc not only in C3H10T1/2 cells but also in N1511
chondrocytes (Fig. 4c). In contrast, WT-Nkx3.2 did not upregulate
activity of the D4Col2E-Luc construct (Fig. 4b, c). We also used
the ChIP assay to determine whether Nkx3.2 bound to the 48 bp
Col2a1 enhancer element, and found that Nkx3.2 did bind to this
enhancer element (Fig. 4d).
Overexpression of Nkx3.2 partially restored
downregulation of GAG production, Col2 protein
expression, and Col2a1 mRNA expression induced by
si-Sox9
To assess Sox9-independent upregulation of Col2a1 trascription
by Nkx3.2, we performed Sox9 inhibiting experiments using RNAi.
On days 5, 7, and 10, GAG production was downregulated by
si-Sox9 compared to si-control (Fig. 5a). Si-Sox9 downregulated
Col2a1 mRNA expression from day 2 and Sox9 mRNA expression
from day 0, while Sox9 mRNA was restored on day 10 (Fig. 5c).
Overexpression of Nkx3.2 upregulated its mRNA expression from
day 0 to day 10, and partially restored downregulation of GAG
production and Col2 protein expression induced by si-Sox9 (Fig. 5a,
b). Overexpression of Nkx3.2 with si-Sox9 upregulated Col2a1
mRNA expression even more than that of si-control+MOCK, and
also tended to restore Sox9 mRNA expression downregulated by
si-Sox9 suggesting positive feedback of Nkx3.2 to Sox9 (Fig. 5c).
Discussion
Previously, we presented the hypothesis that factors other than
Sox9 directly promote chondrogenic differentiation [6]. Here, we
tested our hypothesis by assessing whether Nkx3.2, a well-known
transcriptional repressor of Runx2, directly regulates Col2a1,a
marker of chondrogenesis [8,16].
Downregulation of Nkx3.2 in mouse embryos results in severe
skeletal dysplasia and death [10]. Interestingly, arrested develop-
ment of the intervertebral discs in Nkx3.2 null mice [12] is clearly
reminiscent of the defects observed in Col2a1 null mice [12]. These
findings led us to suppose that Nkx3.2 may play a crucial role in the
regulation of Col2a1 expression.
Previously, it has been reported that Nkx3.2 gene expression
begins somewhat earlier than Sox9 expression during chondro-
genic differentiation in C3H10T1/2 cells [8]. Here, we found that
exogenous Nkx3.2-mediated upregulation of a chondrogenic gene,
Col2a1, occurred earlier than Nkx3.2-mediated upregulation of
Sox9 (Fig. 2a, b). In addition, overexpression of Nkx3.2 partially
restored downregulation of GAG production, Col2 protein
expression, and Col2a1 mRNA expression induced by si-Sox9,
suggesting Sox9-independent mechanism for upregulation of
Col2a1 trascription by Nkx3.2.
Nkx3.2 reportedly binds to a HRAGTG motif [17]. Notably,
we discovered a GTGAAT motif in the Col2a1 enhancer element,
and GTGAAT is the reverse of HRAGTG. Therefore, we
speculated that Nkx3.2 may bind this reverse motif and regulate
Col2a1 transcription. We assessed the effects of overexpression of
Nkx3.2 or Sox9 on Col2a1 enhancer activity using the 4Col2E-Luc
and D4Col2E-Luc constructs. These assays clearly demonstrated
that Nkx3.2 overexpression upregulated 4Col2E-Luc activity, but
Nkx3.2 overexpression had less of an effect than Sox9 overex-
pression. In addition, D4Col2E-Luc transcriptional activity was
not upregulated by WT-Nkx3.2 overexpression, but WT-Sox9
overexpression resulted in upregulation of D4Col2E-Luc. We
suppose that WT-Sox9 was able to upregulate D4Col2E-Luc
because the 42-bp repeats in D4Col2E-Luc each contained three
Sox-9 binding sites [15,18]. Taken together, these results indicate
that the GTGAAT motif in the 48-bp Col2a1 enhancer was
important for the transcriptional activation mediated by either
Nkx3.2 or Sox9. Finally, results of ChIP assays confirmed that
Nkx3.2 did bind to the 48-bp Col2a1 enhancer.
Reportedly, a trio of Sox proteins (Sox9, L-Sox5, and Sox6) is
crucial to upregulation of Col2a1 transcription [18]. However,
Sox9-dependent transcriptional regulation in chondrogenesis
requires cofactors in addition to these Sox proteins, such as
Table 3. Primer sequences used in PCR assays.
gene Primer Sequence (59R39)
Nkx3.2 Forward AACCATCAGCGCTACCTGTC
Reverse CTTTACGGCCACTTTCTTGG
Col2a1 Forward CCTGTCTGCTTCTTGTAAAAC
Reverse AAAAAATACAGAGGTGTTTGACACAGA
Sox9 Forward ATGAATCTCCTGGACCCCTT
Reverse AACTTTGCCAGCTTGCACGT
Runx2 Forward GCTTGATGACTCTAAACCTA
Reverse AAAAAGGGCCCAGTTCTGAA
GAPDH Forward TGAACGGGAAGCTCACTGG
Reverse TCCACCACCCTGTTGCTGTA
doi:10.1371/journal.pone.0034703.t003
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activated receptor c (PPAR-c) coactivator-1a (PGC-1a), and
Smad3 [19,20,21,22,23]. Therefore, we first assumed that Nkx3.2
and some Sox family proteins cooperate to upregulate Col2a1
enhancer activity. Meanwhile, our preliminary experiment showed
that overexpression of Nkx3.2 and Sox9 together was more
effective than overexpression of Nkx3.2 alone, but less effective
than overexpression of Sox9 alone, in upregulating Col2a1
enhancer activity (data not shown). Finally, exogenous Nkx3.2
partially restored GAG production, Col2 protein expression, and
Col2a1 mRNA expression downregulated by si-Sox9. Meanwhile,
exogenous Nkx3.2 also tended to restore Sox9 after day 2, and this
positive feedback may partially contribute to the restoration of
GAG production and Col2a1 mRNA expression by Sox9-
dependent pathway. To obtain stronger downregulation of Sox9,
we performed higher dose of si-Sox9 experiments, which resulted
Figure 1. Overexpression of Nkx3.2 and inhibition of Nkx3.2 affected GAG production and cell proliferation in C3H10T1/2 cell
culture. a After 24-h transfection with MOCK plasmid (upper wells) or WT-Nkx3.2 (lower wells) (day 0), C3H10T1/2 cells were stimulated with BMP-2
(300 ng/ml) for 5, 7, or 10 days. At each time point, cells were stained with alcian blue. b Quantification of GAG synthesis by C3H10T1/2 cells on day 5.
Data are shown as mean 6 S.D. (n=3). ***P,0.001. c Proliferation of C3H10T1/2 cells transfected with MOCK or WT-Nkx3.2 plasmid. Transfected
C3H10T1/2 cells were stimulated with BMP-2 (300 ng/ml) for 8 days. Cell proliferation was assayed on day 2, 5, and 8. **P,0.01; N.S., not significant.
d After a 48-h transfection with negative control siRNA (upper wells) or with Nkx3.2 siRNA (lower wells) (day 0), C3H10T1/2 cells were stimulated with
BMP-2 (300 ng/ml) for 5, 7, or 10 days. At each time point, cells were stained with alcian blue. e Quantification of GAG synthesis by C3H10T1/2 cells
on day 5. Data are means 6 S.D. (n=3). ***P,0.001. f Proliferation of C3H10T1/2 cells transfected with si-control or si-Nkx3.2. Transfected C3H10T1/2
cells were stimulated with BMP-2 (300 ng/ml) for 8 days. Cell proliferation was assayed on days 2, 5, and 8. ***P,0.001; N.S., not significant.
doi:10.1371/journal.pone.0034703.g001
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findings, it seemed that Nkx3.2 could induce chondrogenesis by
Sox9-independent mechanisms in C3H10T1/2 cells, but that it
was less effective than Sox9.
Nkx3.2 expression is maintained in proliferative chondrocytes,
and Nkx3.2 promotes viability of these cells by constitutively
activating RelA during endochondral ossification [24]. Therefore,
we first assumed that Nkx3.2 also controls the viability of
C3H10T1/2 cells stimulated with BMP2. As shown in Fig. 1c
and Fig. 1f, overexpression of Nkx3.2 upregulated and inhibition
of Nkx3.2 downregulated C3H10T1/2 cell proliferation on day 2,
but there was no significant difference from days 5 to 8. Our
quantitative RT-PCR data showed that expression of type X collagen
a1 (Col10a1), a hypertrophic chondrocyte marker, was detected
from day 5 (data not shown). Although it is difficult to demonstrate
that the phenotype of C3H10T1/2 cells stimulated with BMP2 for
2 days is similar to that of proliferative chondrocyte, it is plausible
that Nkx3.2 affected cell proliferation in proliferative chondrocyte,
while its effect seemed to vanish in hypertrophic chondrocytes.
This study has several limitations. We used only two cell lines in
this study; therefore, we must investigate the interactions between
Nkx3.2 and Col2a1 transcription in primary cell culture in future
studies. In addition, we attempted to detect direct binding of
Nkx3.2 to the 48-bp Col2a1 enhancer using electrophoresis
Figure 2. Overexpression of Nkx3.2 and inhibition of Nkx3.2 affected mRNA expression of chondrogenic differentiation markers in
C3H10T1/2 cell culture. a After 24-h transfection with MOCK plasmid or WT-Nkx3.2, C3H10T1/2 cells were stimulated with BMP-2 (300 ng/ml) for 5,
7, and 10 days and total RNA was extracted at each time point. RT-PCR was used to assess Nkx3.2, Sox9, Col2a1, Runx2, and GAPDH mRNA expression.
b Real-time PCR for Col2a1, Sox9, Runx2, and GAPDH mRNAs were also performed. Values are normalized to the level of GAPDH mRNA. Data are
presented as means 6 S.D. (n=3). *P,0.05; **P,0.01; ***P,0.001; N.S., not significant. c After a 48-h transfection with negative control siRNA or with
Nkx3.2 siRNA (day 0), C3H10T1/2 cells were stimulated with BMP-2 (300 ng/ml) for 2, 5, and 7days. At each time point, total RNA was extracted. RT-
PCR was used to assess Nkx3.2, Sox9, Col2a1, Runx2, and GAPDH mRNA expression. d Real-time PCR was also used to assess Col2a1, Sox9, Runx2, and
GAPDH mRNA expression. Values are normalized to the level of GAPDH mRNA. Data are presented as means 6 S.D. (n=3). *P,0.05; **P,0.01;
***P,0.001.
doi:10.1371/journal.pone.0034703.g002
Figure 3. Schematic of reporter constructs. 4Col2E-Luc has four tandem copies of a 48-bp chondrocyte-specific enhancer segment from the
type II collagen a1 (Col2a1) gene. D4Col2E-Luc construct has four tandem copies of a 42-bp version of the 48-bp segment; a GTGAAT motif was
deleted from the 48-bp chondrocyte-specific enhancer segment from Col2a1 to generate the 42-bp version.
doi:10.1371/journal.pone.0034703.g003
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transfected with WT-Nkx3.2 and 48-bp Col2a1 probes and
antibody targeting Nkx3.2. However, we could not detect a clear
supershift; this result may have been due to some unsolvable
difficulties (data not shown). Further confirmation is required to
determine whether Nkx3.2 binds directly to the 48-bp Col2a1
enhancer.
In conclusion, we have demonstrated for the first time that the
Nkx3.2 transcription factor promoted primary chondrogenesis via
binding to Col2a1 enhancer element followed by upregulation of
Col2a1 transcription by both Sox9-dependent and Sox9-indepen-
dent mechanisms.
Acknowledgments
The authors thank Dr. Riko Nishimura (Department of Biochemistry,
Osaka University Graduate School, Faculty of Dentistry) for donating the
wild-type Sox9 (WT-Sox9) plasmid. We also thank Osteopharma Inc. for
supplying recombinant human BMP-2 and Dr. Hideto Watanabe and Dr.
Nobuhiro Kamiya for donating the N1511 cells.
Author Contributions
Conceived and designed the experiments: YK MH KE KS JH AM.
Performed the experiments: YK YH. Analyzed the data: YK YH KE.
Contributed reagents/materials/analysis tools: YK. Wrote the paper: YK
MH KE. Obtained permission for use of cell line: HY AM.
Figure 4. Nkx3.2 upregulated 48-bp Col2a1 enhancer activity in C3H10T1/2 cells (a and b) and in N1511 cells (c) and binds to 48-bp Col2a1 enhancer
(d). a Transient transfection of Nkx3.2 showed does-dependent activation of 4Col2E-Luc. b Transcriptional activity of 4Col2E-Luc and D4Col2E-Luc
using WT-Nkx3.2. Activation by WT-Sox9 is shown as a positive control. *P,0.05; **P,0.01; ***P,0.001; N.S., not significant. c Transient transfection
of Nkx3.2 resulted in activation of the 4Col2E-Luc construct in N1511 cells. In contrast, the D4Col2E-Luc construct was not activated by Nkx3.2
overexpression. **P,0.01; N.S., not significant. d Chromatin immunoprecipitation was performed using Nkx3.2, Sox9, and control antibodies in
C3H10T1/2 cells. Products were obtained from PCR of immunoprecipitated chromatin with primers for the Col2a1 enhancer. The sizes of the products
are indicated. The first lane in each panel shows the PCR product obtained with chromatin input. Data are representative of three independent
experiments.
doi:10.1371/journal.pone.0034703.g004
Nkx3.2 Promotes Chondrogenesis
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34703References
1. Provot S, Schipani E (2005) Molecular mechanisms of endochondral bone
development. Biochem Biophys Res Commun 328: 658–665.
2. Han Y, Lefebvre V (2008) L-Sox5 and Sox6 drive expression of the aggrecan
gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol
Cell Biol 28: 4999–5013.
3. Akiyama H (2008) Control of chondrogenesis by the transcription factor Sox9.
Mod Rheumatol 18: 213–219.
4. Inada M, Yasui T, Nomura S, Miyake S, Deguchi K, et al. (1999) Maturational
disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214: 279–290.
5. Kim IS, Otto F, Zabel B, Mundlos S (1999) Regulation of chondrocyte
differentiation by Cbfa1. Mech Dev 80: 159–170.
6. Hirao M, Tamai N, Tsumaki N, Yoshikawa H, Myoui A (2006) Oxygen tension
regulates chondrocyte differentiation and function during endochondral
ossification. J Biol Chem 281: 31079–31092.
7. Zeng L, Kempf H, Murtaugh LC, Sato ME, Lassar AB (2002) Shh establishes an
Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce
somitic chondrogenesis. Genes Dev 16: 1990–2005.
8. Lengner CJ, Hassan MQ, Serra RW, Lepper C, van Wijnen AJ, et al. (2005)
Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation.
J Biol Chem 280: 15872–15879.
9. Tribioli C, Lufkin T (1999) The murine Bapx1 homeobox gene plays a critical
role in embryonic development of the axial skeleton and spleen. Development
126: 5699–5711.
10. Lettice LA, Purdie LA, Carlson GJ, Kilanowski F, Dorin J, et al. (1999) The
mouse bagpipe gene controls development of axial skeleton, skull, and spleen.
Proc Natl Acad Sci U S A 96: 9695–9700.
11. Hellemans J, Simon M, Dheedene A, Alanay Y, Mihci E, et al. (2009)
Homozygous inactivating mutations in the NKX3-2 gene result in spondylo-
megaepiphyseal-metaphyseal dysplasia. Am J Hum Genet 85: 916–922.
12. Akazawa H, Komuro I, Sugitani Y, Yazaki Y, Nagai R, et al. (2000) Targeted
disruption of the homeobox transcription factor Bapx1 results in lethal skeletal
dysplasia with asplenia and gastroduodenal malformation. Genes Cells 5:
499–513.
13. Aszodi A, Chan D, Hunziker E, Bateman JF, Fassler R (1998) Collagen II is
essential for the removal of the notochord and the formation of intervertebral
discs. J Cell Biol 143: 1399–1412.
14. Kamiya N, Jikko A, Kimata K, Damsky C, Shimizu K, et al. (2002)
Establishment of a novel chondrocytic cell line N1511 derived from p53-null
mice. J Bone Miner Res 17: 1832–1842.
15. Lefebvre V, Zhou G, Mukhopadhyay K, Smith CN, Zhang Z, et al. (1996) An
18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for
expression in cartilage and binds nuclear proteins that are selectively expressed
in chondrocytes. Mol Cell Biol 16: 4512–4523.
16. Yamashita S, Andoh M, Ueno-Kudoh H, Sato T, Miyaki S, et al. (2009) Sox9
directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes. Exp
Cell Res 315: 2231–2240.
17. Kim DW, Kempf H, Chen RE, Lassar AB (2003) Characterization of Nkx3.2
DNA binding specificity and its requirement for somitic chondrogenesis. The
Journal of biological chemistry 278: 27532–27539.
18. Lefebvre V, Li P, de Crombrugghe B (1998) A new long form of Sox5 (L-Sox5),
Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the
type II collagen gene. The EMBO journal 17: 5718–5733.
Figure 5. Overexpression of Nkx3.2 partially restored downregulation of GAG production (a), Col2 protein expression (b), and Col2a1 mRNA
expression (c) induced by si-Sox9 in C3H10T1/2 cell culture. a After 24-h transfection with si-control (upper panels) or si-Sox9 (lower panels), MOCK
plasmid (upper wells) or WT-Nkx3.2 (lower wells) were transfected. After another 24-h culture (day 0), cells were stimulated with BMP-2 (300 ng/ml)
for 5, 7, and 10 days. At each time point, cells were stained with alcian blue. b Western blot of Col2 on day 7. Overexpression of Nkx3.2 partially
restored Col2 protein expression downregulated by si-Sox9. c Total RNA was extracted at each time point. Real-time PCR was used to assess Col2a1,
Nkx3.2, Sox9, and GAPDH mRNA expression. Values are normalized to the level of GAPDH mRNA. Data are presented as means 6 S.D. (n=3). P values
are evaluated v.s. si-control+MOCK group. *P,0.05; **P,0.01; ***P,0.001; no marks represents no significant differences.
doi:10.1371/journal.pone.0034703.g005
Nkx3.2 Promotes Chondrogenesis
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e3470319. Bernard P, Tang P, Liu S, Dewing P, Harley VR, et al. (2003) Dimerization of
SOX9 is required for chondrogenesis, but not for sex determination. Human
molecular genetics 12: 1755–1765.
20. Tsuda M, Takahashi S, Takahashi Y, Asahara H (2003) Transcriptional co-
activators CREB-binding protein and p300 regulate chondrocyte-specific gene
expression via association with Sox9. The Journal of biological chemistry 278:
27224–27229.
21. Kawakami Y, Tsuda M, Takahashi S, Taniguchi N, Esteban CR, et al. (2005)
Transcriptional coactivator PGC-1alpha regulates chondrogenesis via associa-
tion with Sox9. Proceedings of the National Academy of Sciences of the United
States of America 102: 2414–2419.
22. Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, et al. (2005) Sox9 and
p300 cooperatively regulate chromatin-mediated transcription. The Journal of
biological chemistry 280: 35203–35208.
23. Furumatsu T, Tsuda M, Taniguchi N, Tajima Y, Asahara H (2005) Smad3
induces chondrogenesis through the activation of SOX9 via CREB-
binding protein/p300 recruitment. The Journal of biological chemistry 280:
8343–8350.
24. Park M, Yong Y, Choi SW, Kim JH, Lee JE, et al. (2007) Constitutive RelA
activation mediated by Nkx3.2 controls chondrocyte viability. Nature cell
biology 9: 287–298.
Nkx3.2 Promotes Chondrogenesis
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e34703